Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates.
Xinwen HuangDingwen WuLin ZhuWenjun WangRulai YangJianbin YangQunyan HeBingquan ZhuYing YouRui XiaoZheng-Yan ZhaoPublished in: Orphanet journal of rare diseases (2022)
Analysis based on next generation sequencing could effectively identify neonates affected with more congenital disorders. Combined with C-NBS, this approach may improve the early and accurate identification of neonates with inborn disorders. Our study lays the foundation for prospective studies and for implementing NGS-based analysis in NBS.